Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Polo-like Kinase 1 (PLK1) Expression is Associated with Cell Proliferative Activity and Cdc2 Expression in Malignant Lymphoma of the Thyroid

YASUHIRO ITO, HIROSHI YOSHIDA, FUMIO MATSUZUKA, NARIAKI MATSUURA, YASUSHI NAKAMURA, HIROKAZU NAKAMINE, KENNICHI KAKUDO, KANJI KUMA and AKIRA MIYAUCHI
Anticancer Research January 2004, 24 (1) 259-264;
YASUHIRO ITO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROSHI YOSHIDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FUMIO MATSUZUKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NARIAKI MATSUURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUSHI NAKAMURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROKAZU NAKAMINE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENNICHI KAKUDO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KANJI KUMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIRA MIYAUCHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Polo-like kinase 1 (PLK1) is one of the serine threonine kinases that plays a role in cellular proliferation by activating the CDC25C-CDK1 (cdc2) loop. We recently demonstrated that cdc2 expression is associated with the biological aggressiveness of malignant lymphoma of the thyroid. In this study, we investigated PLK1 expression in thyroid lymphoma in order to elucidate its physiological significance in this disease. Materials and Methods: We immunohistochemically investigated PLK1 expression in 46 cases of thyroid lymphoma and 10 cases of chronic thyroiditis. Results: Normal follicular cells did not express PLK1, whereas follicular cells in those in chronic thyroiditis and malignant lymphoma demonstrated a high level of PLK1 expression. In lymphocytes in chronic thyroiditis with strong lymphocyte infiltration, PLK1 was weakly expressed. In malignant lymphoma, PLK1 expression was observed in all cases, but PLK1 was more strongly expressed in cases with high cell proliferative activity and with cdc2 expression. Conclusion: These results suggest that PLK1 regulates the cell cycle progression of thyroid lymphoma cells in the G2-M-phase.

  • Received September 16, 2003.
  • Accepted December 2, 2003.
  • Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 24 (1)
Anticancer Research
Vol. 24, Issue 1
January-February 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Polo-like Kinase 1 (PLK1) Expression is Associated with Cell Proliferative Activity and Cdc2 Expression in Malignant Lymphoma of the Thyroid
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Polo-like Kinase 1 (PLK1) Expression is Associated with Cell Proliferative Activity and Cdc2 Expression in Malignant Lymphoma of the Thyroid
YASUHIRO ITO, HIROSHI YOSHIDA, FUMIO MATSUZUKA, NARIAKI MATSUURA, YASUSHI NAKAMURA, HIROKAZU NAKAMINE, KENNICHI KAKUDO, KANJI KUMA, AKIRA MIYAUCHI
Anticancer Research Jan 2004, 24 (1) 259-264;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Polo-like Kinase 1 (PLK1) Expression is Associated with Cell Proliferative Activity and Cdc2 Expression in Malignant Lymphoma of the Thyroid
YASUHIRO ITO, HIROSHI YOSHIDA, FUMIO MATSUZUKA, NARIAKI MATSUURA, YASUSHI NAKAMURA, HIROKAZU NAKAMINE, KENNICHI KAKUDO, KANJI KUMA, AKIRA MIYAUCHI
Anticancer Research Jan 2004, 24 (1) 259-264;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • PLK1 and YY1 interaction in follicular lymphoma is associated with unfavourable outcome
  • Google Scholar

More in this TOC Section

  • Tumor Budding Grade and T Stage as Recurrence Predictors of High-risk Stage II Colorectal Cancer
  • Pathologic Complete Response (pCR) in Patient With Myxofibrosarcoma Who Underwent Neoadjuvant Radiation Concurrent to Complementary and Alternative Medicine
  • Machine Learning Model to Guide Empirical Antimicrobial Therapy in Febrile Neutropenic Patients With Hematologic Malignancies
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire